Neuroblastoma Drugs Business Research Report 2023-2030: Evolving Landscape of Combination Therapies Expands Addressable Market Opportunities
21 août 2024 10h45 HE
|
Research and Markets
Dublin, Aug. 21, 2024 (GLOBE NEWSWIRE) -- The "Neuroblastoma Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Neuroblastoma...